Aprea Therapeutics Investor Relations Material
Latest events
Study Update
Aprea Therapeutics
Corporate Presentation
12 Aug, 2025
Q2 2025
12 Aug, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Aprea Therapeutics Inc
Access all reports
Aprea Therapeutics Inc. is a biopharmaceutical company focused on developing cancer treatments. The company specializes in small-molecule therapies that target tumor suppressor pathways to address various malignancies. Its research and development efforts aim to enhance the effectiveness of existing treatments and explore novel therapeutic approaches. The company is headquartered in Doylestown, Pennsylvania, and its shares are listed on the NASDAQ.
Key slides for Aprea Therapeutics Inc
Corporate Presentation
Aprea Therapeutics Inc
Corporate Presentation
Aprea Therapeutics Inc
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
APRE
Country
🇺🇸 United States